BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 12549901)

  • 1. MAP kinases and CDKs: kinetic basis for catalytic activation.
    Lew J
    Biochemistry; 2003 Feb; 42(4):849-56. PubMed ID: 12549901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of cyclin-dependent kinase regulation: structures of Cdks, their cyclin activators, and Cip and INK4 inhibitors.
    Pavletich NP
    J Mol Biol; 1999 Apr; 287(5):821-8. PubMed ID: 10222191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of vascular smooth muscle cell growth by magnesium-role of mitogen-activated protein kinases.
    Touyz RM; Yao G
    J Cell Physiol; 2003 Dec; 197(3):326-35. PubMed ID: 14566962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Roles of mitogen activated protein kinases and EGF receptor in arsenite-stimulated matrix metalloproteinase-9 production.
    Cooper KL; Myers TA; Rosenberg M; Chavez M; Hudson LG
    Toxicol Appl Pharmacol; 2004 Nov; 200(3):177-85. PubMed ID: 15504454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New insights into the catalytic activation of the MAPK phosphatase PAC-1 induced by its substrate MAPK ERK2 binding.
    Zhang Q; Muller M; Chen CH; Zeng L; Farooq A; Zhou MM
    J Mol Biol; 2005 Dec; 354(4):777-88. PubMed ID: 16288922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective role of Bcl-2 on beta-amyloid-induced cell death of differentiated PC12 cells: reduction of NF-kappaB and p38 MAP kinase activation.
    Song YS; Park HJ; Kim SY; Lee SH; Yoo HS; Lee HS; Lee MK; Oh KW; Kang SK; Lee SE; Hong JT
    Neurosci Res; 2004 May; 49(1):69-80. PubMed ID: 15099705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of MAP kinase by muscarinic cholinergic receptors induces cell proliferation and protein synthesis in human breast cancer cells.
    Jiménez E; Montiel M
    J Cell Physiol; 2005 Aug; 204(2):678-86. PubMed ID: 15744749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apoptotic and mitogenic stimuli inactivate Rb by differential utilization of p38 and cyclin-dependent kinases.
    Nath N; Wang S; Betts V; Knudsen E; Chellappan S
    Oncogene; 2003 Sep; 22(38):5986-94. PubMed ID: 12955077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphorylation of the Pro-X-Thr-Pro site in phosphatase inhibitor-2 by cyclin-dependent protein kinase during M-phase of the cell cycle.
    Li M; Stefansson B; Wang W; Schaefer EM; Brautigan DL
    Cell Signal; 2006 Aug; 18(8):1318-26. PubMed ID: 16377132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Catalysis and function of the p38 alpha.MK2a signaling complex.
    Lukas SM; Kroe RR; Wildeson J; Peet GW; Frego L; Davidson W; Ingraham RH; Pargellis CA; Labadia ME; Werneburg BG
    Biochemistry; 2004 Aug; 43(31):9950-60. PubMed ID: 15287722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An allosteric mechanism for activation of the kinase domain of epidermal growth factor receptor.
    Zhang X; Gureasko J; Shen K; Cole PA; Kuriyan J
    Cell; 2006 Jun; 125(6):1137-49. PubMed ID: 16777603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel ERK-like, CRK-like protein kinase that modulates growth in Trypanosoma brucei via an autoregulatory C-terminal extension.
    Ellis J; Sarkar M; Hendriks E; Matthews K
    Mol Microbiol; 2004 Sep; 53(5):1487-99. PubMed ID: 15387824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of the SNT-1/FRS2 phosphotyrosine binding domain inhibits activation of MAP kinase and PI3-kinase pathways and antiestrogen resistant growth induced by FGF-1 in human breast carcinoma cells.
    Manuvakhova M; Thottassery JV; Hays S; Qu Z; Rentz SS; Westbrook L; Kern FG
    Oncogene; 2006 Sep; 25(44):6003-14. PubMed ID: 16682955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.
    Unni E; Sun S; Nan B; McPhaul MJ; Cheskis B; Mancini MA; Marcelli M
    Cancer Res; 2004 Oct; 64(19):7156-68. PubMed ID: 15466214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Density functional study of the enzymatic reaction catalyzed by a cyclin-dependent kinase.
    Cavalli A; De Vivo M; Recanatini M
    Chem Commun (Camb); 2003 Jun; (11):1308-9. PubMed ID: 12809244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MAP kinases.
    Chen Z; Gibson TB; Robinson F; Silvestro L; Pearson G; Xu B; Wright A; Vanderbilt C; Cobb MH
    Chem Rev; 2001 Aug; 101(8):2449-76. PubMed ID: 11749383
    [No Abstract]   [Full Text] [Related]  

  • 17. Preclinical evidence of multiple mechanisms underlying trastuzumab resistance in gastric cancer.
    Arienti C; Zanoni M; Pignatta S; Del Rio A; Carloni S; Tebaldi M; Tedaldi G; Tesei A
    Oncotarget; 2016 Apr; 7(14):18424-39. PubMed ID: 26919099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of Aurora-A kinase by protein partner binding and phosphorylation are independent and synergistic.
    Dodson CA; Bayliss R
    J Biol Chem; 2012 Jan; 287(2):1150-7. PubMed ID: 22094468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene expression profiling of monkeypox virus-infected cells reveals novel interfaces for host-virus interactions.
    Alkhalil A; Hammamieh R; Hardick J; Ichou MA; Jett M; Ibrahim S
    Virol J; 2010 Jul; 7():173. PubMed ID: 20667104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peptide reporters of kinase activity in whole cell lysates.
    Wu D; Sylvester JE; Parker LL; Zhou G; Kron SJ
    Biopolymers; 2010; 94(4):475-86. PubMed ID: 20593469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.